MAGDELENE RODRIGUEZ: Open Payments
NPI 1154091965 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,133 in 226 payments from 26 companies in 2025. Trend: 2023 $1,914 · 2024 $6,628 · 2025 $15,133
Consulting: $6,400Food & beverage: $5,277Travel & lodging: $1,946Speaker / faculty: $1,500Education: $10
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 21 | $7,726 |
| Genentech USA, Inc. | 26 | $1,902 |
| Janssen Biotech, Inc. | 2 | $1,405 |
| EMD Serono, Inc. | 17 | $686 |
| ABBVIE INC. | 41 | $519 |
| Novartis Pharmaceuticals Corporation | 29 | $518 |
| Eisai Inc. | 12 | $317 |
| ARGENX US, INC. | 11 | $284 |
| Lundbeck LLC | 10 | $268 |
| Vanda Pharmaceuticals Inc. | 9 | $267 |
Products named: Zilbrysq, Ocrevus, KESIMPTA, Leqembi, UBRELVY, VYEPTI, PONVORY, Ocrevus Zunovo.
Industry payments across TX — which companies pay providers there.
